Charity makes three research awards

Article

One of the world's leading eye research centres, the UCL Institute of Ophthalmology, has been awarded three PhD studentships worth £280,000 tenable from October 2009.

One of the world's leading eye research centres, the UCL Institute of Ophthalmology, has been awarded three PhD studentships worth £280,000 tenable from October 2009. They were awarded from Fight for Sight, a UK leading charity dedicated to funding research into the prevention and treatment of blindness and eye disease.

The awards will enable researchers to develop new treatments for patients with conditions affecting the retina and the cornea.

The studentships will be allocated for supervision under the following members of staff at the UCL Institute of Ophthalmology:

Professor Robin Ali and Mr Frank Larkin will supervise an award for research into a viral gene therapy that could enhance the quality of donor corneas stored in eye banks, leading to less wastage, and improved functionality and longevity for transplanted corneas.

Professor Mike Cheetham will oversee the award for research into key molecular components that help in the manufacture of rhodopsin (a transmembrane protein) within the cell and the protection against the formation of its faulty form. Once identified, these components will be targets for new therapies to treat rhodopsin retinitis pigmentosa, one of the most common causes of inherited blindness.

Finally, Professor Shin-ichi Ohnuma and Dr Yamamoto Yoshiyuki will preside over the award for a study into genetically determined diseases of the cornea that may lead to blindness. This research will explore options for therapies to treat these diseases.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.